Bgm (BGM) Retained Earnings (2019 - 2025)
Bgm (BGM) posted quarterly Retained Earnings of $399.0 million for Q3 2025, up 995.87% year-over-year from $36.4 million in Q3 2024, and up 125.89% quarter-over-quarter from $176.6 million in Q1 2025.
Bgm (BGM) Retained Earnings (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Retained Earnings for 7 consecutive years, with $399.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Retained Earnings rose 995.87% year-over-year to $399.0 million; the TTM figure through Sep 2025 stood at $399.0 million (up 995.87% YoY), while the FY2025 annual figure was $399.0 million, up 995.87% from the prior year.
- Retained Earnings grew to $399.0 million in Q3 2025 per BGM's latest filing, from $176.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $36410.9 billion in Q1 2023 and bottomed at $36.4 million in Q3 2021.
- Historically, Retained Earnings has averaged $8089.2 billion across 5 years, with a median of $36.4 million in 2022.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 100.0% — and 2025, when it soared 995.87%.
- Bgm's Retained Earnings stood at $36.4 million in 2021, then grew by 0.05% to $36.4 million in 2022, then changed by 0.0% to $36.4 million in 2023, then changed by 0.0% to $36.4 million in 2024, then jumped by 995.87% to $399.0 million in 2025.
- Business Quant data shows BGM's Retained Earnings at $399.0 million in Q3 2025, $176.6 million in Q1 2025, and $36.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 399.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 399.02 Mn |
| Mar 31, 2025 | 176.64 Mn |
| Sep 30, 2024 | 36.41 Mn |
| Mar 31, 2024 | 36.41 Mn |
| Sep 30, 2023 | 36.41 Mn |
| Mar 31, 2023 | 36,410.93 Bn |
| Sep 30, 2022 | 36.41 Mn |
| Mar 31, 2022 | 36,390.93 Bn |
| Sep 30, 2021 | 36.39 Mn |
| Sep 30, 2020 | 12.25 Mn |
| Sep 30, 2019 | 12.25 Mn |